Table 2 Clinical and demographical features of healthy individuals and AS patients
Group | CO individuals (n = 14) | AS patients (n = 14) |
|---|---|---|
Female/Male (%) | 3/11 (21/79%) | 3/11 (21/79%) |
Age, years | 32 ± 9.6 | 32 ± 10 |
Smoking, % | 35 | 35 |
ESR, mm/h (SD) | 5 (3) | 37 (19) |
Disease duration, years | - | 7.5 ± 6 |
HLA-B27 positivity, % | - | 71 |
BASMI score (SD) | - | 3.7 (2.5) |
BASDAI score (SD) | - | 6.1 (1.9) |
BASFI score (SD) | - | 4.6 (2.7) |
PGDA score‌ (SD) | - | 7 (2.7) |
BASG score (SD) | - | 7.2 (1.8) |
ASQoL score (SD) | - | 9.5 (5.6) |
Biological agents, % | 0 | 0 |